SPL 0.00% 9.4¢ starpharma holdings limited

Ann: App 4E/Annual Report to shareholders, page-16

  1. 12,865 Posts.
    lightbulb Created with Sketch. 1414
    35.2 million cash end of June 2023 + 6.6 million Mundipharma cash + 7.6 million R&D = 49.8 million

    Minus 10 million to December 2023 quarter

    Minus 5 million in loans

    We should have access to 35 million (includes net $2 million R&D due Financial year 2024


    Our net cash position should be around 35 million December quarter 2023

    This will not include any milestone payments and cash revenue from licensed products and any upfront fees from licensees

    No need for any capital raising any time soon
 
watchlist Created with Sketch. Add SPL (ASX) to my watchlist
(20min delay)
Last
9.4¢
Change
0.000(0.00%)
Mkt cap ! $38.76M
Open High Low Value Volume
9.4¢ 9.4¢ 9.4¢ $481 5.115K

Buyers (Bids)

No. Vol. Price($)
1 249999 9.3¢
 

Sellers (Offers)

Price($) Vol. No.
9.8¢ 65000 1
View Market Depth
Last trade - 11.47am 09/08/2024 (20 minute delay) ?
SPL (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.